EpiCeram

DRUG4 trials

Sponsors

Wake Forest University Health Sciences, Stanford University, University of Melbourne, Primus Pharmaceuticals

Conditions

Allergy;FoodAsthmaAtopic DermatitisDermatitis, AtopicEczemaIrritant Contact Dermatitis

Phase 1

Effect of Different Skin Creams on TEWL

CompletedNCT03663673

Stanford UniversityDermatitis, Atopic

Start: 2018-09-01End: 2019-07-18Updated: 2021-09-08

Phase 3

The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants

Active, not recruitingNCT03667651

University of MelbourneAllergy;Food, Asthma, Eczema

Start: 2018-03-06End: 2027-05-31Target: 760Updated: 2023-05-10

Phase 4

Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis

CompletedNCT01093469

Wake Forest University Health SciencesAtopic Dermatitis

Start: 2009-09-30End: 2010-02-28Updated: 2018-09-11

Unknown Phase

EpiCeram for Skin Protection in Healthcare Workers

TerminatedNCT04793711

Primus PharmaceuticalsIrritant Contact Dermatitis

Start: 2021-03-15End: 2021-07-01Updated: 2024-08-28

Related Papers

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.

2020-02-19178 citations

PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy

BMJ Open2019-03-0164 citations

An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.

2011-05-0165 citations